Evidence map›Paper›PMID 26047535›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2015

The use of human cornea organotypic cultures to study herpes simplex virus type 1 (HSV-1)-induced inflammation.

Peter Drevets, Ana Chucair-Elliott, Priyadarsini Shrestha, Jeremy Jinkins, Dimitrios Karamichos, Daniel J J Carr

Abstract read
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Peter DrevetsDepartment of Ophthalmology, Dean A. McGee Eye Institute, Acers Pavilion, 415A, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd., Oklahoma City, OK, 73104, USA.
Ana Chucair-ElliottDepartment of Ophthalmology, Dean A. McGee Eye Institute, Acers Pavilion, 415A, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd., Oklahoma City, OK, 73104, USA.
Priyadarsini ShresthaDepartment of Ophthalmology, Dean A. McGee Eye Institute, Acers Pavilion, 415A, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd., Oklahoma City, OK, 73104, USA.
Jeremy JinkinsDepartment of Ophthalmology, Dean A. McGee Eye Institute, Acers Pavilion, 415A, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd., Oklahoma City, OK, 73104, USA.
Dimitrios KaramichosDepartment of Ophthalmology, Dean A. McGee Eye Institute, Acers Pavilion, 415A, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd., Oklahoma City, OK, 73104, USA.
Daniel J J CarrDepartment of Ophthalmology, Dean A. McGee Eye Institute, Acers Pavilion, 415A, University of Oklahoma Health Sciences Center, 608 Stanton L. Young Blvd., Oklahoma City, OK, 73104, USA. dan-carr@ouhsc.edu.
Dean McGee Eye Institute · USUniversity of Oklahoma Health Sciences Center · US

Funding

P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan, MICHAEL H ELLIOTT · 2011 to 2026
$10.5M
Corneal Lymphatics & Adaptive ImmunityR01EY021238 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI CARR, DANIEL J · 2011 to 2020
$3.6M
Documentation of Novel Keratoconus Markers: In Vitro and In VivoR01EY023568 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI KARAMICHOS, DIMITRIOS · 2013 to 2015
$1.1M
NEI NIH HHS EY021725NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY021238NEI NIH HHS R01 EY021238-05NEI NIH HHS R01 EY023568NEI NIH HHS R01 EY023568-02
6 · The paper itself

Abstract

purposeTo determine the utility of human organotypic cornea cultures as a model to study herpes simplex virus type 1 (HSV-1)-induced inflammation and neovascularization.

methodsHuman organotypic cornea cultures were established from corneas with an intact limbus that were retrieved from donated whole globes. One cornea culture was infected with HSV-1 (10(4) plaque-forming units), while the other cornea from the same donor was mock-infected. Supernatants were collected at intervals post-culture with and without infection to determine viral titer (by plaque assay) and pro-angiogenic and proinflammatory cytokine concentration by suspension array analysis. In some experiments, the cultured corneas were collected and evaluated for HSV-1 antigens by immunohistochemical means. Another set of experiments measured susceptibility of human three-dimensional cornea fibroblast constructs, in the presence and absence of TGF-β1, to HSV-1 infection in terms of viral replication and the inflammatory response to infection as a comparison to the organotypic cornea cultures.

resultsOrganotypic cornea cultures and three-dimensional fibroblast constructs exhibited varying degrees of susceptibility to HSV-1. Fibroblast constructs were more susceptible to infection in terms of infectious virus recovered in a shorter period of time. There were changes in the levels of select pro-angiogenic or proinflammatory cytokines that were dictated as much by the cultures producing them as by whether they were infected with HSV-1 or treated with TGF-β1.

conclusionOrganotypic cornea and three-dimensional fibroblast cultures are likely useful for the identification and short-term study of novel antiviral compounds and virus replication, but are limited in the study of the local immune response to infection.

Indexed as

Antigens, ViralCells, CulturedCorneaCorneal KeratocytesCorneal NeovascularizationCytokinesFluorescent Antibody Technique, IndirectHerpesvirus 1, HumanHumansKeratitis, HerpeticOrgan Culture TechniquesTissue DonorsTransforming Growth Factor beta1Vascular Endothelial Growth Factor CViral LoadVirus ReplicationAntigens, ViralCytokinesTransforming Growth Factor beta1Vascular Endothelial Growth Factor CCorneaCytokinesHSV-1InflammationPro-angiogenic factors

Identifiers

PMID26047535
PMCPMC4573349
OpenAlexW610778462

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.